Finnegan attorney Bob Kramer will participate in the panel discussion “U.S. Patentable Subject Matter,” at Australia's Medtech Conference. The conference will examine the major factors in global medtech success, outline key commercial issues, and provide updates in the fields of IP, regulatory approvals, health economics, and sales networks. The conference will take place at the Adelaide Convention and Exhibition Center in Adelaide, Australia. For more information, or to register, please see the AusBiotech website.
INCONTESTABLE® Blog
March 1, 2024
Ad Law Buzz Blog
Natural-ish: A New Decision Underscores NAD’s Expansive Understanding of Natural Claims
January 26, 2024
Prosecution First Blog
I Forgot! Retroactive Foreign Filing License Petitions for U.S. Inventors
December 1, 2023
INCONTESTABLE® Blog
September 14, 2023
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.